Mata Nathan L.'s Form 4 filing
Belite Bio, Inc (BLTE) · filed May 6, 2026
- Accession no.
- 0001193125-26-209004
- Filed
- May 6, 2026
- Trade date
- May 5, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $155.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mata Nathan L.CIK 0002013987 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | American depositary share | SSaleDisposed | −120 | $153.92F3 | −$18,470.4 | 2,546 | Direct | |
| May 5, 2026 | American depositary share | SSaleDisposed | −363 | $154.44F4 | −$56,061.72 | 2,183 | Direct | |
| May 5, 2026 | American depositary share | SSaleDisposed | −173 | $155.48F5 | −$26,898.04 | 2,010 | Direct | |
| May 5, 2026 | American depositary share | SSaleDisposed | −121 | $156.53F6 | −$18,940.13 | 1,889 | Direct | |
| May 5, 2026 | American depositary share | SSaleDisposed | −155 | $157.29F7 | −$24,379.95 | 1,734 | Direct | |
| May 5, 2026 | American depositary share | SSaleDisposed | −68 | $158.11 | −$10,751.48 | 1,666 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average price of shares sold at prices that ranged from $153.92 to $153.93. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of shares sold at prices that ranged from $154.01 to $154.955. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average price of shares sold at prices that ranged from $155.04 to $155.91. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average price of shares sold at prices that ranged from $156.005 to $156.94. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents the weighted average price of shares sold at prices that ranged from $157.035 to $157.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.